3655 results for «398»
3655 results
Most impactful trials in structural heart disease 2024/2025
30 Sep 2025 – From PCR Gulf Valves 2025
Delve into the most impactful structural heart disease trials shaping 2024 and 2025. This session addresses current dilemmas in TAVI, including early intervention and management of small annuli, evaluates evidence for transcatheter mitral and tricuspid valve repair, and identifies evidence gaps relevant to the region, providing...
Second valve strategies with SAPIEN 3 Ultra RESILIA
30 Sep 2025 – From PCR Gulf Valves 2025
Gain key insights into managing second valve interventions with the SAPIEN 3 Ultra RESILIA system.
This session helps you anticipate and address complex scenarios such as mitral valve-in-valve, TAV-in-SAV, and valve-in-valve-in-valve procedures. Learn from expert case discussions that explore procedural strategies, technical challenges, and best practices to...
Abstracts and challenging clinical cases
30 Sep 2025 – From PCR Gulf Valves 2025
Engage with a dynamic collection of abstracts and challenging clinical cases that highlight the latest advances and investigative studies in interventional cardiology. Topics include innovative approaches to aortic stenosis management, AI-powered procedural planning, hemodynamic insights beyond traditional imaging, and complex valve interventions, providing a comprehensive overview...
3D echocardiography for structural procedures
30 Sep 2025 – From PCR Gulf Valves 2025
This session provides an in-depth understanding of three-dimensional (3D) echocardiography in structural heart procedures. Learn how to optimize 3D echocardiographic imaging for various valve interventions, including mitral valve procedures, and gain practical skills through hands-on training to enhance procedural guidance and outcomes.
Complex femoral access for TAVI in bicuspid aortic stenosis - LIVE Case
30 Sep 2025 – From PCR Gulf Valves 2025
A 74-year-old male with a history of multiple PCIs, peripheral arterial disease, and type 2 DM presented with symptomatic bicuspid aortic stenosis and preserved LV function.
A 26 mm Myval valve was implanted via right femoral artery access, with right radial secondary access, following predilatation with a...
Echocardiography for mitral valvuloplasty ballooning
30 Sep 2025 – From PCR Gulf Valves 2025
Enhance your expertise in echocardiography assessment and intraprocedural guidance for mitral valvuloplasty ballooning. This session focuses on evaluating mitral stenosis, distinguishing suitable from non-suitable candidates, and offers practical, hands-on experience to optimize procedural outcomes using echocardiographic techniques.
PCR Gulf Valves 2025 Closing Ceremony
30 Sep 2025 – From PCR Gulf Valves 2025
Join the PCR Gulf Valves 2025 Closing Ceremony to reflect on the advancements and highlights of this year’s sessions dedicated to valvular interventions. This event marks the culmination of comprehensive educational activities, fostering collaboration and innovation in valvular heart disease management within the Gulf region.
PCR Gulf Valves 2025 Opening Ceremony
29 Sep 2025 – From PCR Gulf Valves 2025
Join us for the PCR Gulf Valves 2025 Opening Ceremony, marking the commencement of an exceptional congress dedicated to advances in structural heart interventions. This session sets the stage for the latest innovations and expert discussions that will shape the future of valve therapies in the...
2026 Andreas Grüntzig Ethica Awardee: Roxana Mehran
20 May 2026
The Andreas Grüntzig Ethica Award – the highest honour in the interventional cardiology community – is presented to individuals who have contributed in an extraordinary way to the PCR mission.
SEISMIC-HF I - Exploring non-invasive methods for monitoring intracardiac filling pressures
16 Nov 2024
Luis Ortega provides his take on the SEISMIC-HF I study presented by Liviu Klein at AHA 2024, in Chicago.
Author
Why hypertension is a major unresolved problem
02 Oct 2024
Explore the global challenge of hypertension, affecting one in three adults, and the strategies for screening, diagnosis, and management, including lifestyle modifications, pharmacotherapy, and device-based treatments, as outlined by Sofie Brouwers.
Author
EuroPCR 2026 – Long-term mortality following revascularisation for left main disease
20 May 2026
Paris, France, 19−22 May 2026. The EuroPCR Course Directors have selected 3 major late-breaking trials that will be presented for the first time during EuroPCR 2026 and are set to impact practice worldwide. Among them is a meta-analysis of long-term data from 4 randomised trials investigating...
Promising Safety and Efficacy Results for Supraflex Cruz in HBR Subset Analysis from FIRE Trial, with 1-Month DAPT
03 Nov 2023
Impella percutaneous ventricular assist device malrotation in social media: a call to action
20 Apr 2023
The data from this study suggest that, from a SoMe perspective, correct Impella orientation is often overlooked, and that Impella malrotation is a common issue in real-world clinical practice, potentially associated with relevant complications.
Author
Author
Author
Author
Author
The 2023 ESH Hypertension Guidelines revisit the role of renal denervation
05 Sep 2023
The 2023 European Society of Hypertension (ESH) guidelines were recently presented at the 32nd annual European Meeting on Hypertension and Cardiovascular Protection and simultaneously published in the Journal of Hypertension.1 While wide parts of the guidelines do not substantially differ from the previous 2018 European Society...
Author
Author
